Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
DW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.5.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.75.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
XAKNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XAANSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-19568.4US
BQ.1.30NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.50NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.515NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.258.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
B.1.370NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.118NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.137NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.309NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.632NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.72NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.108NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.332NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.42.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.596.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.473NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.595.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.76.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.38.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.357NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.111NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.336NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.400.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.537NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.548NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.24.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.492NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.540NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.487NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.430NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.331NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.112.3 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used